Welcome to BaselBC - Basel Breast Consortium

Next event:

  • Jun 14 2016 12:30: Lunchtime meeting
    Hospital,  Seminar room, ZLF, 2nd floor, Hebelstrasse 20, 4031 Basel, Lunch provided

    Primo Schär (DBM): Department of Biomedicine, University Basel
    Hans-Jörg Senn: Tumour and Breast Center (ZeTuP), St. Gallen
    Heidi Lane: Basilea Pharmaceutica International Ltd, Basel
    » View poster

The Basel Breast Consortium is an interdisciplinary organization committed to the development of basic, clinical and translational research projects by supporting interdisciplinary communication and mutual education in Switzerland and neighbouring cities. The presence of outstanding basic science groups, a university hospital and a medical faculty with strong clinical oncology departments, and numerous pharma companies make Basel well-positioned to be the nexus of these collaborative activities.

To discuss, design and conduct scientific projects with the potential to advance knowledge in breast cancer basic biology and therapy to the highest level of targeted therapeutic efficacy while minimizing treatment-related toxicity.

The consortium’s mission is accomplished by regular meetings and networking opportunities among basic researchers, translational research scientists, clinicians - from academia and industry - dedicated to the study of mammary gland development, as well as breast cancer research and treatment in Switzerland and neighbouring cities. Participating clinicians and researchers may have a designated interest in basic or clinical research and originate from the fields of plastic, oncologic and oncoplastic surgery, radiation and medical oncology, gynecology, pathology, radiology and genetics. Participating basic researchers may originate, among others, from a variety of disciplines, including basic cell biology, genetics, immunology, computational biology, endocrinology and fundamental molecular biology.

We organize four joint lunchtime tandem meetings per year. The format is three 15 minutes presentations from basic/translational researchers, clinicians, and industry, while providing 15 additional minutes for discussion and networking.
We are confident that these interactions promote fruitful collaborations in the fields of breast development and breast cancer in Switzerland and neighbouring cities.


  • Mohamed Bentires-Alj (Momo), Pharm, Ph.D. Senior staff scientist, Friedrich Miescher Institute for Biomedical Research (FMI)
  • Walter P. Weber, Prof. Dr. Chief, Breast Surgery Unit, University Hospital of Basel
  • Christoph Rochlitz, Prof. Dr. Head of the Tumour Center of the University Hospital Basel
    Webpage - Oncology department - CCRC website
  • Gerhard Christofori, Prof. Dr. Department of Biomedicine, University of Basel


BBC honorary members

  • Prof. Max Burger
  • Prof. Dr. med. Hans-Jörg Senn
  • Prof. Felix Harder
  • Prof. Richard Herrmann
  • Prof. Nancy Hynes
  • Prof. Peter Meier-Abt

Upcoming Events

  • Jun 14 2016 12:30: Lunchtime meeting

    Hospital, Seminar room, ZLF, 2nd floor, Hebelstrasse 20, 4031 Basel, Lunch provided
    Read more
  • Sep 6 2016 12:30: Lunchtime meeting

    FMI, Room 5.30, Lunch provided
    Read more
  • Nov 17 2016 8:00: BBC first annual meeting: Personalized breast cancer treatments

    Read more


Please communicate your new publications and awards in the fields of breast development and cancer to M. Bentires-Alj.

May 23 2016: Press release: Basel network for breast cancer research expands to Europe (in German)


April 27 2016: We are happy to welcome Prof. Nancy Hynes as a honorary member

"...the practice of medicine will become increasingly interdisciplinary, requiring clinicians to work with biologists and physicists, chemists, engineers, and computational experts to deal with diagnostics and to invent novel ways to intervene..."
"We must also think about time scales. The university must pursue fundamental discovery research for long-term benefits, translational research for the medium-term application, and patients-based application for short-term, if not immediate results. All three must find their place in a dialogue within the faculty."

From "The future of medicine" (Schwabe Verlag Basel 2013, 10-22) by Susan M. Gasser, FMI Director.